307 related articles for article (PubMed ID: 19438819)
21. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
Glass DJ; Harper AS
BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
[TBL] [Abstract][Full Text] [Related]
22. Second-generation antihistamines for the treatment of chronic idiopathic urticaria.
Belsito DV
J Drugs Dermatol; 2010 May; 9(5):503-12. PubMed ID: 20480793
[TBL] [Abstract][Full Text] [Related]
23. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
Kapp A; Pichler WJ
Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
[TBL] [Abstract][Full Text] [Related]
24. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
Potter P; Mitha E; Barkai L; Mezei G; Santamaría E; Izquierdo I; Maurer M
Pediatr Allergy Immunol; 2016 Feb; 27(1):55-61. PubMed ID: 26267219
[TBL] [Abstract][Full Text] [Related]
25. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life.
Grob JJ; Auquier P; Dreyfus I; Ortonne JP
Allergy; 2009 Apr; 64(4):605-12. PubMed ID: 19133920
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Dubertret L; Murrieta Aguttes M; Tonet J
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
[TBL] [Abstract][Full Text] [Related]
27. Desloratadine therapy for symptoms associated with perennial allergic rhinitis.
Kim K; Sussman G; Hébert J; Lumry W; Lutsky B; Gates D
Ann Allergy Asthma Immunol; 2006 Mar; 96(3):460-5. PubMed ID: 16597081
[TBL] [Abstract][Full Text] [Related]
28. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
29. Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H(1) -antihistamine dose escalation.
Magerl M; Pisarevskaja D; Staubach P; Martus P; Church MK; Maurer M
Br J Dermatol; 2012 May; 166(5):1095-9. PubMed ID: 22242678
[TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria.
Hong JB; Lee HC; Hu FC; Chu CY
J Am Acad Dermatol; 2010 Nov; 63(5):e100-2. PubMed ID: 20950731
[No Abstract] [Full Text] [Related]
31. The safety and efficacy of desloratadine for the management of allergic disease.
Berger WE
Drug Saf; 2005; 28(12):1101-18. PubMed ID: 16329713
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
Zuberbier T; Oanta A; Bogacka E; Medina I; Wesel F; Uhl P; Antépara I; Jáuregui I; Valiente R;
Allergy; 2010 Apr; 65(4):516-28. PubMed ID: 19860762
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
[TBL] [Abstract][Full Text] [Related]
34. Adult and paediatric poor metabolisers of desloratadine: an assessment of pharmacokinetics and safety.
Prenner B; Kim K; Gupta S; Khalilieh S; Kantesaria B; Manitpisitkul P; Lorber R; Wang Z; Lutsky B
Expert Opin Drug Saf; 2006 Mar; 5(2):211-23. PubMed ID: 16503743
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria.
Khalaf AT; Liu XM; Sheng WX; Tan JQ; Abdalla AN
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):487-92. PubMed ID: 18081747
[TBL] [Abstract][Full Text] [Related]
36. Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study.
Weller K; Ardelean E; Scholz E; Martus P; Zuberbier T; Maurer M
Acta Derm Venereol; 2013 Mar; 93(2):168-74. PubMed ID: 23053062
[TBL] [Abstract][Full Text] [Related]
37. Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria.
Kulthanan K; Gritiyarangsan P; Sitakalin C; Charuwichitratana S; Korkij W; Aunhachoke K; Janjumratsang P; Jiamton S; Kuntiranont M; Krisadapong J; Gherunpong N; Kullavanijaya P
J Med Assoc Thai; 2001 Feb; 84(2):153-9. PubMed ID: 11336071
[TBL] [Abstract][Full Text] [Related]
38. Desloratadine: a nonsedating antihistamine.
Limon L; Kockler DR
Ann Pharmacother; 2003 Feb; 37(2):237-46; quiz 313-6. PubMed ID: 12549956
[TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
Devillier P; Roche N; Faisy C
Clin Pharmacokinet; 2008; 47(4):217-30. PubMed ID: 18336052
[TBL] [Abstract][Full Text] [Related]
40. Evidence for clinical safety, efficacy, and parent and physician perceptions of levocetirizine for the treatment of children with allergic disease.
Pampura AN; Papadopoulos NG; Spičák V; Kurzawa R
Int Arch Allergy Immunol; 2011; 155(4):367-78. PubMed ID: 21346367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
